Ampio Pharmaceuticals (AMPE) News Today $0.0026 0.00 (0.00%) (As of 01:34 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.comDecember 26 at 2:45 AM | americanbankingnews.comStockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)December 18, 2024 | americanbankingnews.comAmpio Pharmaceuticals (OTC:AMPE) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comAmpio Pharmaceuticals, Inc. (AMPE)May 17, 2024 | finance.yahoo.comAmpio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationApril 3, 2024 | finance.yahoo.comAmpio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationApril 3, 2024 | prnewswire.comAMPE Stock Earnings: Ampio Pharmaceuticals Reported Results for Q4 2023March 27, 2024 | investorplace.comAmpio Pharmaceuticals IncMarch 26, 2024 | money.usnews.comAmpio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC DeregistrationMarch 26, 2024 | finanznachrichten.deUS Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence ReadingsMarch 26, 2024 | msn.comAmpio Announces Voluntary Delisting and SEC DeregistrationMarch 25, 2024 | finance.yahoo.comAmpio Pharmaceuticals, Ironwood, Incannex among healthcare moversFebruary 29, 2024 | msn.comAmpio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling StudiesFebruary 15, 2024 | finanznachrichten.deAmpio Provides Update on Results from Pre-IND Enabling StudiesFebruary 14, 2024 | prnewswire.comAmpio Pharmaceuticals Announces At-The-Market Stock OfferingJanuary 26, 2024 | msn.comSociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' packDecember 28, 2023 | seekingalpha.comWhat's Going On With Ampio Pharmaceuticals Stock?December 1, 2023 | msn.comRedhill Biopharma, Ampio Pharmaceuticals among healthcare moversDecember 1, 2023 | msn.comThinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly GroupNovember 30, 2023 | benzinga.comAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201October 5, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference 63 Day 2 on October 5 Register NowOctober 4, 2023 | finance.yahoo.comAmpio Pharmaceuticals to Present at the Emerging Growth ConferenceSeptember 26, 2023 | finance.yahoo.comAmpio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary EndpointSeptember 7, 2023 | thestreet.comAmpio Pharmaceuticals announces 20-to-1 reverse stock splitAugust 31, 2023 | seekingalpha.comAmpio Pharmaceuticals Board Approves Reverse Stock Split - Quick FactsAugust 31, 2023 | markets.businessinsider.comAmpio Pharmaceuticals Announces Reverse Stock SplitAugust 31, 2023 | finance.yahoo.comThinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?August 3, 2023 | benzinga.com3 Biotech Stocks to Buy With Explosive Upside PotentialJune 22, 2023 | msn.comAMPE - Ampio Pharmaceuticals, Inc.June 3, 2023 | finance.yahoo.comAmpio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockMay 26, 2023 | finance.yahoo.comAmpio stock jumps ~20% after CEO letter on drug program, reorganizationApril 18, 2023 | seekingalpha.comAmpio Too Busy to Tell Investors Results of Eye Drug StudyApril 3, 2023 | thestreet.comWhy Ampio Pharmaceuticals (AMPE) Stock Is Plummeting TodayFebruary 9, 2023 | thestreet.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.February 7, 2023 | wsj.comAmpio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsDecember 27, 2022 | finance.yahoo.comAmpio Pharmaceuticals Announces NYSE American Removal of Trading SuspensionNovember 17, 2022 | finance.yahoo.comAmpio Pharmaceuticals Announces Fifteen-to-One Reverse Stock SplitNovember 8, 2022 | finance.yahoo.comMONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmOctober 16, 2022 | stockhouse.comAMPE DEADLINE TOMORROW: ROSEN, skilled investor counsel, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important October 17 Deadline in Securities Class Action - AMPEOctober 16, 2022 | prnewswire.comMONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmOctober 12, 2022 | benzinga.comROSEN, LEADING INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPEOctober 7, 2022 | prnewswire.comAmpio Pharmaceuticals Announces NYSE American Has Commenced Delisting ProceedingsOctober 4, 2022 | markets.businessinsider.comNYSE American to Suspend Trading Immediately in Ampio Pharmaceuticals, Inc. (AMPE) and Commence Delisting ProceedingsOctober 3, 2022 | benzinga.comCLASS ACTION UPDATE for AMPE, TWTR and CNTA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 30, 2022 | benzinga.comROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPESeptember 28, 2022 | prnewswire.comAMPE Class Action Alert: If you Lost Money In Ampio Ampio Pharmaceuticals, Inc. (AMPE) Contact Robbins LLP for Information About Your RightsSeptember 23, 2022 | benzinga.comAMPE LAWSUIT ALERT: Levi & Korsinsky Notifies Ampio Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSeptember 22, 2022 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ampio Pharmaceuticals, Inc. – AMPESeptember 21, 2022 | benzinga.comWhy ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving PremarketSeptember 21, 2022 | benzinga.comAMPE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Ampio Pharmaceuticals, Inc. ShareholdersSeptember 20, 2022 | prnewswire.com Get Ampio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW AMPE Media Mentions By Week AMPE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPE News Sentiment▼0.000.64▲Average Medical News Sentiment AMPE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPE Articles This Week▼10▲AMPE Articles Average Week Get Ampio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Navidea Biopharmaceuticals News Today eFFECTOR Therapeutics News Today biote News Today BriaCell Therapeutics News Today Clever Leaves News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AMPE) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe Key to Feeding 8.1 Billion PeopleImagine a mineral so small it fits in the palm of your hand... yet its potential could transform the world's f...i2i Marketing Group, LLC | SponsoredIs Jeff Bezos Crowning the Next Nvidia?It doesn't matter what you think about AI... Because Jeff Bezos's massive load-up on one tiny tech company ...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
